• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Matthew Perrone

Stay informed with Matthew Perrone’s coverage and analysis.

Conflicting court rulings put access to widely-used abortion pill mifepristone into question
HealthConflicting court rulings put access to widely-used abortion pill mifepristone into question
By Paul J. Weber, Matthew Perrone and The Associated PressApril 7, 2023
Makena
HealthFDA orders immediate withdrawal of only drug approved for preterm birth prevention
By Matthew Perrone and The Associated PressApril 6, 2023
Unproven birth drug that symbolized the FDA’s struggle to pull drugs from the market is finally withdrawn
HealthUnproven birth drug that symbolized the FDA’s struggle to pull drugs from the market is finally withdrawn
By Matthew Perrone and The Associated PressMarch 8, 2023
The FDA is using YouTube and Twitter to try and tackle ‘a leading cause of death in America’: Online misinformation
HealthThe FDA is using YouTube and Twitter to try and tackle ‘a leading cause of death in America’: Online misinformation
By Matthew Perrone and The Associated PressFebruary 21, 2023
New lawsuits target abortion pill restrictions in North Carolina and West Virginia
PoliticsNew lawsuits target abortion pill restrictions in North Carolina and West Virginia
By Matthew Perrone and The Associated PressJanuary 26, 2023
U.S. proposes streamlining COVID vaccinations by making them once-a-year—like a flu shot
HealthU.S. proposes streamlining COVID vaccinations by making them once-a-year—like a flu shot
By Matthew Perrone and The Associated PressJanuary 23, 2023
FDA Commissioner Robert Califf
HealthThe first drug to have even a limited impact on Alzheimer’s just got FDA approval. ‘This drug is not a cure.’
By Matthew Perrone and The Associated PressJanuary 6, 2023
Joe Biden
HealthThe FDA just finalized a Biden rule change to make abortion pills much more widely available at pharmacies nationwide
By Matthew Perrone and The Associated PressJanuary 4, 2023
ALS patients face dilemma over drug’s $158K price tag: ‘I’m not going to spend all my money on this’
HealthALS patients face dilemma over drug’s $158K price tag: ‘I’m not going to spend all my money on this’
By Matthew Perrone and The Associated PressDecember 18, 2022
FDA
HealthThe FDA’s speedy approval of experimental new drugs came to a screeching halt this year
By Matthew Perrone and The Associated PressDecember 7, 2022
Man with IV
HealthIf you have hemophilia, you can now get a one-time gene therapy for $3.5 million
By Matthew Perrone and The Associated PressNovember 23, 2022
Juul
RetailLayoffs aren’t just hitting tech. Juul is eliminating hundreds of jobs.
By Matthew Perrone and The Associated PressNovember 10, 2022
Jeffrey Reed
HealthPhilips told millions of people it will eventually replace their sleeping devices that emit hazardous chemicals. That was over a year ago.
By Matthew Perrone and The Associated PressOctober 25, 2022
Juul to pay nearly $440 million to settle states’ investigation into marketing of its e-cigarettes to teens
HealthJuul to pay nearly $440 million to settle states’ investigation into marketing of its e-cigarettes to teens
By Matthew Perrone, Dave Collins and The Associated PressSeptember 6, 2022
Hearing aids
HealthFDA approves over-the-counter hearing aids in the U.S.
By Matthew Perrone and The Associated PressAugust 16, 2022
1...
  • 3
  • 4
  • 5
  • 6
  • 7
8
Most Popular
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeJune 25, 2026
Success
Philanthropy leader at Warren Buffett and Bill Gates’ Giving Pledge says children of billionaires are pushing them to give their wealth away fasterplaceholder alt text
By Preston ForeJune 27, 2026
Success
Ex-Google engineer says Larry Page, Sergey Brin and Sundar Pichai share the same trait—it's the lesson he swears by as a $7.2 billion AI CEOplaceholder alt text
By Orianna Rosa RoyleJune 28, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our and Privacy Policy |  | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.